BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 15814227)

  • 41. An appraisal of the bioavailability enhancers in Ayurveda in the light of recent pharmacological advances.
    Singh S; Tripathi JS; Rai NP
    Ayu; 2016; 37(1):3-10. PubMed ID: 28827948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioavailability enhancers of herbal origin: an overview.
    Kesarwani K; Gupta R; Mukerjee A
    Asian Pac J Trop Biomed; 2013 Apr; 3(4):253-66. PubMed ID: 23620848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of absorption enhancers on cytoskeletal actin filaments in Caco-2 cell monolayers.
    Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M
    Life Sci; 1998; 63(1):45-54. PubMed ID: 9667764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro and in vivo evaluation of the enhancing activity of glycyrrhizin on the intestinal absorption of drugs.
    Imai T; Sakai M; Ohtake H; Azuma H; Otagiri M
    Pharm Res; 1999 Jan; 16(1):80-6. PubMed ID: 9950283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy.
    Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M
    J Pharm Sci; 1997 Jul; 86(7):779-85. PubMed ID: 9232516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simultaneous use of sodium deoxycholate and dipotassium glycyrrhizinate enhances the cellular transport of poorly absorbed compounds across Caco-2 cell monolayers.
    Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M
    J Pharm Pharmacol; 1999 Jan; 51(1):27-33. PubMed ID: 10197414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytotoxicity of absorption enhancers in Caco-2 cell monolayers.
    Sakai M; Imai T; Ohtake H; Otagiri M
    J Pharm Pharmacol; 1998 Oct; 50(10):1101-8. PubMed ID: 9821655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absorption-enhancing effect of glycyrrhizin induced in the presence of capric acid.
    Imai T; Sakai M; Ohtake H; Azuma H; Otagiri M
    Int J Pharm; 2005 Apr; 294(1-2):11-21. PubMed ID: 15814227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2007; 26 Suppl 2():79-112. PubMed ID: 17613133
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.